ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,847Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 457

$1.84M Total Retail Price of All Prescriptions

Rank: 10 out of 457

521 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 19,015 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

48% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$84 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
OMEPRAZOLE 704 637 1 1
LIDODERM 637 503 2 31
CRESTOR 633 529 3 9
NEXIUM 622 514 4 12
LISINOPRIL 578 532 5 3
ADVAIR DISKUS 505 406 6 27
SIMVASTATIN 488 446 7 2
IBUPROFEN 477 405 8 14
AMLODIPINE BESYLATE 449 391 9 4
METFORMIN HCL 440 355 10 6
SINGULAIR 417 348 11 43
VOLTAREN 402 348 12 34
DIOVAN 390 358 13 30
NAMENDA 365 353 14 32
ZOLPIDEM TARTRATE 358 334 15 13
CLOPIDOGREL 349 311 16 19
LYRICA 319 252 17 77
PLAVIX 313 285 18 24
LEVOTHYROXINE SODIUM 301 288 19 5
DEXILANT 290 275 20 118
ACTOS 279 204 21 105
TRAMADOL HCL 273 223 22 26
LOVAZA 272 229 23 50
RANITIDINE HCL 262 233 24 17
METOPROLOL TARTRATE 262 241 24 7
NOVOLIN 70-30 256 189 26 113
DONEPEZIL HCL 247 223 27 22
SPIRIVA 237 232 28 101
JANUVIA 223 180 29 80
ATENOLOL 223 200 29 11
TAMSULOSIN HCL 222 206 31 36
CELEBREX 221 202 32 53
FUROSEMIDE 182 162 33 10
LANTUS 179 158 34 56
MONTELUKAST SODIUM 178 146 35 86
CILOSTAZOL 177 148 36 88
GABAPENTIN 176 160 37 15
MECLIZINE HCL 163 157 38 55
INSULIN SYRINGE 162 145 39 79
SURE COMFORT 157 142 40 103
AMMONIUM LACTATE 156 145 41 82
MELOXICAM 151 132 42 41
DIOVAN HCT 150 148 43 51
PROAIR HFA 146 128 44 66
PENTOXIFYLLINE 146 134 44 67
ATORVASTATIN CALCIUM 146 120 44 33
POTASSIUM CHLORIDE 144 123 47 28
GLYBURIDE-METFORMIN HCL 143 136 R 48 70
LOSARTAN POTASSIUM 136 90 49 18
CLOTRIMAZOLE-BETAMETHASONE 129 109 50 60
EXELON 124 124 51 98
TRICOR 121 88 52 83
CARVEDILOL 121 92 52 20
HYDROCHLOROTHIAZIDE 118 92 54 8
METOPROLOL SUCCINATE 113 105 55 21
AMLODIPINE BESYLATE-BENAZEPRIL 107 94 56 72
SYMBICORT 103 96 57 106
GLIPIZIDE 102 85 58 42
ALLOPURINOL 101 97 59 47
ESCITALOPRAM OXALATE 98 97 60 61
AVODART 97 93 61 110
DICLOFENAC SODIUM 96 87 62 49
FLUTICASONE PROPIONATE 95 74 63 40
FAMOTIDINE 95 91 63 62
ENALAPRIL MALEATE 94 65 65 35
PAROXETINE HCL 94 88 65 68
KETOCONAZOLE 92 67 67 92
DETROL LA 91 81 68 262
MOMETASONE FUROATE 91 71 68 267
NOVOLOG MIX 70-30 90 90 70 190
NAPROXEN 90 79 70 65
JANUMET 84 73 72 154
NASONEX 81 73 73 129
DICYCLOMINE HCL 80 76 74 115
LANSOPRAZOLE 80 75 74 74
LOSARTAN-HYDROCHLOROTHIAZIDE 78 71 76 54
MUPIROCIN 76 53 77 91
GLIMEPIRIDE 75 59 78 75
BENICAR 74 74 79 90
CLONIDINE HCL 74 66 79 52
IBANDRONATE SODIUM 71 71 81 183
PIOGLITAZONE HCL 71 56 R 81 251
DOXAZOSIN MESYLATE 70 70 83 73
EXFORGE 70 70 83 149
PRAVASTATIN SODIUM 70 66 83 29
LISINOPRIL-HYDROCHLOROTHIAZIDE 69 56 86 37
CYMBALTA 67 55 87 97
PANTOPRAZOLE SODIUM 63 57 88 59
VENTOLIN HFA 59 54 89 96
FINASTERIDE 59 59 89 85
CIPROFLOXACIN HCL 58 51 91 71
LIPITOR 57 38 92 205
BONIVA 56 56 93 206
METOCLOPRAMIDE HCL 51 51 94 116
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 28, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.